A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures

SIMPLE SUMMARY: Current therapies for bladder cancer present limitations as, regularly, not all patients benefit from treatment. Drug repurposing refers to the use of available drugs in new disease contexts. In this study, we identified drugs of potential to be repurposed, e.g., used in the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokou, Marika, Lygirou, Vasiliki, Angelioudaki, Ioanna, Paschalidis, Nikolaos, Stroggilos, Rafael, Frantzi, Maria, Latosinska, Agnieszka, Bamias, Aristotelis, Hoffmann, Michèle J., Mischak, Harald, Vlahou, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759896/
https://www.ncbi.nlm.nih.gov/pubmed/33255925
http://dx.doi.org/10.3390/cancers12123519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759896/
https://www.ncbi.nlm.nih.gov/pubmed/33255925
http://dx.doi.org/10.3390/cancers12123519

Ejemplares similares